Characteristics and overall survival in patients with T1 melanoma: A nationwide matched cohort study
International Journal of Cancer · 2026
DOI: 10.1002/ijc.70287 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Ylva Naeser und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Most cutaneous malignant melanomas (CMMs) are thin (≤1.0 mm, stage T1) with an expected 10‐year melanoma‐specific survival of 93%–97%. The incidence of CMM is higher in groups with high socioeconomic status (SES). We aimed to assess overall survival (OS) and detailed characteristics in individuals with thin CMM as compared to the general population matched on age, sex, and county of residence. Matched cohort study comprising patients diagnosed between 2001 and 2018 with thin CMM (cases) and melanoma‐free comparators from the general population. Patients and comparators were identified in the Malignant Melanoma Data Base Sweden. Multivariable Cox regression analyses were applied to compare the mortality risk for cases and comparators with adjustments for SES and comorbidities. We identified 25,843 cases and 127,383 comparators. Cases had higher SES and less comorbidity. No significant differences in OS were found. However, in the T1a subgroup, comprising 16,941 cases, the 5‐year OS was significantly better than in comparators ( n = 83,510) (92.5% (95% CI 92.1%–93.0%) versus 91.1% (95% CI 90.8%–91.3%), p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
- Department of Oncology, Uppsala University Hospital, Uppsala, Sweden.
- Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
- Department of Biomedical and Clinical Sciences, Regional Cancer Center South East Sweden, Linköping, Sweden.
- Department of Surgery, Skåne University Hospital, Kristianstad, Sweden.
- Department of Clinical Sciences, Surgery, Lund University, Lund, Sweden.
ORCID-Profile: Karolin Isaksson, Gustav J Ullenhag
Zitieren
APA
Naeser, Y., Mikiver, R., Isaksson, K., Lambe, M., & Ullenhag, G. J. (2026). Characteristics and overall survival in patients with T1 melanoma: A nationwide matched cohort study. International Journal of Cancer. https://doi.org/10.1002/ijc.70287
Vancouver
Naeser Y, Mikiver R, Isaksson K, Lambe M, Ullenhag GJ. Characteristics and overall survival in patients with T1 melanoma: A nationwide matched cohort study. International Journal of Cancer. 2026. doi:10.1002/ijc.70287
BibTeX
@article{Naeser2026,
author = {Naeser, Ylva and Mikiver, Rasmus and Isaksson, Karolin and Lambe, Mats and Ullenhag, Gustav J},
title = {Characteristics and overall survival in patients with T1 melanoma: A nationwide matched cohort study},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70287}
}
EUVIMED